This adds to the growing body of evidence that AI can act as a disruptor in early lung cancer detection strategies. It can provide an early warning system in countries without formal lung cancer screening programs or complement CT-based screening programs by going beyond smoker/ex-smoker cohorts. By expanding and improving the number of early-detected lung cancer patients, survival rates will increase through early surgical or pharmaceutical interventions. The AI-powered finding enabled timely referral for CT imaging confirmation and biopsy, confirming early-stage lung cancer in all cases. Global market potential — In countries lacking structured lung cancer screening programs, AI-enhanced X-rays could create large, untapped patient populations eligible for therapeutic intervention.